iShares Biotechnology ETF (NASDAQ:IBB) Shares Purchased by Sharper & Granite LLC

Sharper & Granite LLC raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 2.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,250 shares of the financial services provider’s stock after purchasing an additional 170 shares during the period. Sharper & Granite LLC’s holdings in iShares Biotechnology ETF were worth $826,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. PVG Asset Management Corp acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth about $415,000. Huntington National Bank lifted its stake in shares of iShares Biotechnology ETF by 17.9% during the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after buying an additional 160 shares during the period. National Bank of Canada FI boosted its position in iShares Biotechnology ETF by 5.9% during the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after acquiring an additional 229 shares during the last quarter. First Financial Bank Trust Division purchased a new stake in iShares Biotechnology ETF in the 3rd quarter worth approximately $204,000. Finally, Thrive Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the 3rd quarter valued at $445,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

IBB opened at $134.02 on Tuesday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The company’s 50 day simple moving average is $137.95 and its 200 day simple moving average is $141.99.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.